Staphylococcus aureus (S. aureus)-associated bovine mastitis is a serious economic and animal health concern in Nepalese dairy production. Yet, antimicrobial resistance (AMR) data from commercial dairy herds remain scarce. A cross-sectional study was conducted from January to March 2020 in Tilottama Municipality, Rupandehi District, Nepal. A total of 207 lactating cows from 69 commercial dairy farms were enrolled by two-stage cluster sampling. Composite milk samples were pre-enriched in Buffered Peptone Water and cultured on Mannitol Salt Agar. S. aureus was considered positive by a five-step biochemical protocol with the tube coagulase test as the definitive criterion. Antimicrobial susceptibility to six agents was determined by the Kirby-Bauer disk diffusion method, and phenotypic methicillin-resistant S. aureus (MRSA) was identified by cefoxitin (30 µg) disk diffusion. Animal-level S. aureus prevalence was 33.3% (69/207) and herd-level prevalence was 53.6% (37/69). Cefoxitin non-susceptibility was detected in 52.2% of isolates; multidrug resistance (MDR) in 26.1% and a multiple antibiotic resistance (MAR) index ≥0.25 in 71.0% of isolates. Chloramphenicol showed the highest susceptibility rate (92.8%). After Bonferroni correction, animal age ≥5 years (OR=3.88) and early lactation stage ≤6 months post-calving (OR=3.30) were significantly associated with S. aureus positivity. Cefoxitin non-susceptibility and MDR were common among S. aureus isolates from commercial dairy farms of Tilottama Municipality. Older cows as well as early-lactating ones carried the highest infection risk. Culture-guided antimicrobial therapy, improved antibiotic stewardship, and sustained antimicrobial resistance (AMR) surveillance with molecular confirmation are recommended to prevent antimicrobial resistance.
No takes yet. Share an insight, caveat, or question.
Tiwari et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: